The Cooper Companies, Inc. Common Stock (COO)

Price$67.34

Value ScoreC

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-21.51%

Price vs S&P 500 (4W)12.24%

VGM Score52.13

Market Capitalization$13.14B

P/E Ratio (Annual)35.05x

Indicated Dividend Yield (Annual)0.02%

All Metrics

P/CF (Annual)16.50x

Book Value / Share (Quarterly)$42.87

P/TBV (Annual)2.09x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.35%

Cash Flow / Share (Quarterly)$2.52

Payout Ratio (TTM)1.63%

Price vs S&P 500 (YTD)-26.00%

Gross Margin (TTM)65.44%

Net Profit Margin (TTM)9.67%

EPS (TTM)$2.02

10-Day Avg Trading Volume3.90M

EPS Excl Extra (TTM)$2.02

Revenue Growth (5Y)10.98%

EPS (Annual)$1.87

Dividend / Share (Annual)$0.00

ROI (Annual)3.49%

Gross Margin (Annual)65.54%

Net Profit Margin (5Y Avg)27.97%

Cash / Share (Quarterly)$0.64

P/E Basic Excl Extra (TTM)32.73x

Revenue Growth QoQ (YoY)6.16%

EPS Growth (5Y)9.30%

P/E Normalized (Annual)35.05x

ROA (Last FY)3.02%

Revenue Growth TTM (YoY)5.69%

EBITD / Share (TTM)$4.58

ROE (5Y Avg)12.22%

Operating Margin (TTM)17.19%

Cash Flow / Share (Annual)$2.21

P/B Ratio1.57x

P/B Ratio (Quarterly)1.89x

Net Income / Employee (Annual)$25,000

EV / Revenue (TTM)3.74x

Net Interest Coverage (TTM)6.25x

ROA (TTM)3.24%

EPS Growth QoQ (YoY)28.28%

EV / EBITDA (TTM)17.03x

EPS Incl Extra (Annual)$1.87

Current Ratio (Annual)1.89x

Quick Ratio (Quarterly)0.58x

3-Month Avg Trading Volume2.29M

52-Week Price Return-5.39%

EV / Free Cash Flow (Annual)35.77x

P/E Incl Extra (TTM)32.73x

Revenue / Employee (TTM)$276,800

Tangible BV / Share (Quarterly)$34.97

P/S Ratio (Annual)3.21x

Asset Turnover (Annual)0.33x

52-Week High$89.83

Operating Margin (5Y Avg)16.46%

EPS Excl Extra (Annual)$1.87

CapEx CAGR (5Y)3.15%

Tangible BV CAGR (5Y)21.28%

26-Week Price Return-13.59%

Quick Ratio (Annual)0.84x

13-Week Price Return-16.03%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.34x

Enterprise Value$15.51B

Revenue / Share Growth (5Y)10.80%

Asset Turnover (TTM)0.33x

Book Value / Share Growth (5Y)53.92%

Revenue / Employee (Annual)$272,800

Inventory Turnover (Annual)1.71x

Pretax Margin (Annual)13.84%

Cash / Share (Annual)$0.56

3-Month Return Std Dev30.83%

Gross Margin (5Y Avg)66.04%

Net Income / Employee (TTM)$26,800

EBITDA CAGR (5Y)14.46%

EBITDA Interim CAGR (5Y)9.17%

ROE (Last FY)4.55%

Net Interest Coverage (Annual)6.89x

EPS Basic Excl Extra (Annual)$1.87

P/FCF (TTM)26.75x

Receivables Turnover (TTM)5.45x

EV / Free Cash Flow (TTM)31.58x

Total Debt / Equity (Quarterly)0.30x

EPS Incl Extra (TTM)$2.02

Receivables Turnover (Annual)5.29x

ROI (TTM)3.71%

P/S Ratio (TTM)3.16x

Pretax Margin (5Y Avg)14.29%

Revenue / Share (Annual)$20.46

Tangible BV / Share (Annual)$33.96

Forward P/E12.62x

Free OCF CAGR (5Y)19.74%

Price vs S&P 500 (52W)-29.76%

P/E Ratio (TTM)32.73x

EPS Growth TTM (YoY)-2.36%

Year-to-Date Return-17.84%

5-Day Price Return11.88%

EPS Normalized (Annual)$1.87

ROA (5Y Avg)8.55%

Net Profit Margin (Annual)9.16%

Month-to-Date Return10.01%

Cash Flow / Share (TTM)$12.84

EBITD / Share (Annual)$4.41

EPS Growth (3Y)-1.15%

Operating Margin (Annual)16.69%

LT Debt / Equity (Annual)0.30x

P/CF (TTM)15.17x

ROI (5Y Avg)9.79%

P/E Excl Extra (TTM)32.73x

LT Debt / Equity (Quarterly)0.22x

EPS Basic Excl Extra (TTM)$2.02

P/TBV (Quarterly)2.32x

Payout Ratio (Annual)0.78%

P/B Ratio (Annual)1.69x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)1.67x

Pretax Margin (TTM)14.58%

Book Value / Share (Annual)$42.06

Price vs S&P 500 (13W)-24.29%

Net Margin Growth (5Y)-1.36%

Dividend Yield (TTM)0.00%

Beta0.83x

P/FCF (Annual)30.30x

Revenue / Share (TTM)$21.11

ROE (TTM)4.83%

52-Week Low$58.89

vGradeC

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q2 261.21est. 1.11

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.80

3.76

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	Price
COOThe Cooper Companies, Inc. Common Stock	C	C	C	$67.34
ALCAlcon Inc. Ordinary Shares	C	C	C	$66.81
BLCOBausch + Lomb Corporation	B	C	C	$15.46
WRBYWarby Parker Inc.	D	B	C	$22.72
STAAStaar Surgical Co	D	C	A	$29.99
EYENational Vision Holdings, Inc. Common Stock	A	D	D	$15.44
RXSTRxSight, Inc. Common Stock	B	C	F	$5.00
LUCYInnovative Eyewear, Inc. Common Stock	A	A	D	$0.91
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	C	$0.05

About

CooperCompanies operates two leading market segments: CooperVision, which controls approximately 25% of the U.S. contact lens market with brands including Proclear and Biofinity, and CooperSurgical, a reproductive healthcare company with 17% market share in U.S. IUDs and comprehensive IVF device coverage. The company benefits from strong positions in both recurring consumer products and specialized medical devices. CooperVision maintains one of the world's most extensive specialty lens portfolios, while CooperSurgical offers integrated fertility solutions across the IVF cycle.